Challenges in umbilical cord blood stem cell banking for stem cell reviews and reports

Stem Cell Reviews and Reports

Volumn 6, Issue 1, 2010, Pages 8-14

  Ballen, Karen ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Banking; Cord blood; Transplantation

Indexed keywords

ADULT; ANIMAL; ARTICLE; BLOOD BANK; BLOOD DONOR; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; FETUS BLOOD; HUMAN; LABORATORY DIAGNOSIS; ORGANIZATION AND MANAGEMENT; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; ANIMALS; BLOOD BANKS; BLOOD DONORS; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HUMANS; PRIVATE SECTOR; PUBLIC SECTOR; RISK ASSESSMENT; SPECIMEN HANDLING; TREATMENT OUTCOME;

EID: 77949279407     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-009-9105-x     Document Type: Article

References (60)

1. Knudtzon, S. (1974). In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood, 43, 357-361.
2. Broxmeyer, H. E., Kurtzberg, J., Gluckman, E., et al. (1991). Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells, 17, 313-329.
3. Lansdorp, P. M., Dragowska, W., & Mayani, H. (1993). Ontogeny-related changes in proliferative potential of human hematopoietic cells. The Journal of Experimental Medicine, 178, 787-791.
4. Gluckman, E., Broxmeyer, H. A., Auerbach, A. D., et al. (1989). Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA identical sibling. The New England Journal of Medicine, 321, 1174-1178.
5. Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1994). Evidence for a mitotic clock in human hematopoeitic stem cells: loss of telomeric DNA with age. Proceedings of the National Academy of Sciences of the United States of America, 91, 9857-9860.
6. Szabolcs, P., Park, K. D., Reese, M., Marti, L., Broadwater, G., & Kurtzberg, J. (2003). Coexistant naïve phenotype and higher cycling rate of cord blood T cells compared to adult peripheral blood. Experimental Hematology, 31, 708-714.
7. Kim, Y. J., Brutkiewicz, P. R., & Broxmeyer, H. E. (2002). Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells. Blood, 100, 3253-3260.
8. Berthou, C., Legros-Maida, S., Soulie, A., et al. (2003). Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood, 102, 4608.
9. Gluckman, E., Broxmeyer, H. A., Auerbach, A. D., et al. (1989). Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. The New England Journal of Medicine, 321, 1174-1178.
10. Locatelli, F., Rocha, V., Chastang, C., et al. (1999). Factors associated with outcome after cord blood transplantation in children with acute leukemia: Eurocord-Cord Blood Transplant Group. Blood, 93, 3662-3671.
11. Locatelli, F., Rocha, V., Reed, W., et al. (2003). Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood, 101, 2137-2143.
12. Kurtzberg, J., Laughlin, M., Graham, M. L., et al. (1996). Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. The New England Journal of Medicine, 335, 157-166.
13. Eapen, M. (2007). Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lance, 369, 1947-1954.
14. Petterson, T. E., Gabriel, M., Tiedmann, K., et al. (2009). Outcomes following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group. Bone Marrow Transplantation, 43, 207-215.
15. Kurtzberg, J., Prasad, V. K., Carter, S. L., et al. (2008). Results of the cord blood transplantation study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood, 112, 4318-4327.
16. Hwang, W. Y., Samuel, M., Tan, D., Koh, L. P., Lim, W., & Lim, Y. C. (2007). A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biology of Blood and Marrow Transplantation, 13, 444-453.
17. Staba, S. L., Escolar, M. L., Poe, M., et al. (2004). Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. The New England Journal of Medicine, 350, 1960-1969.
18. Escolar, M. L., Poe, M. D., Provenzale, J. M., et al. (2005). Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. The New England Journal of Medicine, 352, 2069-2081.
19. Kobayashi, R., Ariga, T., Nonoyama, S., et al. (2006). Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. British Journal of Haematology, 135, 362-366.
20. Walters, M. C., Quirilo, L., Trachtenberg, E. T., et al. (2005). Sibling donor CB transplantation for thalassemia major: experience of the Sibling Donor Cord Blood Program. Annals of the New York Academy of Sciences, 1054, 206-213.
21. Walters, M. C., Quirolo, L., & Edwards, S. (2007). Directed donor CB transplantation for hematologic disorders. Biology of Blood and Marrow Transplantation, 13(suppl 2), 79a.
22. Laughlin, M. J., Barker, J., Bambach, B., et al. (2001). Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. The New England Journal of Medicine, 344, 1815-1822.
23. Laughlin, M. J., Eapen, M., Rubinstein, P., et al. (2004). Outcomes after transplantation of cord blood or bone marrow from unrelated donors in patients with leukemia. The New England Journal of Medicine, 351, 226-2275.
24. Rocha, V., Labopin, M., Sanz, G., et al. (2004). Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. The New England Journal of Medicine, 351, 2276-2285.
25. Ooi, J., Takahashi, S., Tomonari, A., et al. (2009). Unrelated cord blood transplantation after myeloablative conditioning in adults with ALL. Bone Marrow Transplantation, 43, 455-459.
26. Takahashi, S., Ooi, J., Tomonari, A., et al. (2007). Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem cell transplantation from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood, 109, 1322-1330.
27. Barker, J. N., Weisdorf, D. J., Defor, T. E., et al. (2005). Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 105, 1343-1347.
28. Majhail, S. N., Brunstein, C. G., Tomblyn, M., et al. (2008). Reduced-intensity allogeneic transplantation in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biology of Blood and Marrow Transplantation, 14, 282-289.
29. Cutler, C., Haspel, R., Kao, G., Ho, V., Alyea, E., Koreth, J., et al. (2007). Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Biology of Blood and Marrow Transplantation, 13, 122. 337 a.
30. Ballen, K. K., Spitzer, T. R., Yeap, B., McAfee, S., et al. (2007). Double unrelated reduced intensity umbilical cord blood transplantation in adults. Biology of Blood and Marrow Transplantation, 13, 82-89.
31. Brunstein, C. G., Barker, J. N., Weisdorf, D. J., et al. (2007). Umbilical cord blood transplantation after nonmyeloablative conditioning: impact of transplantation outcomes in 110 adults with hematologic disease. Blood, 110, 3064-3070.
32. Bautista, G., Cabrera, J. R., Regidor, C., et al. (2009). Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplantation, 43, 365-373.
33. de Lima, M., McMannis, J., Gee, A., et al. (2008). Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplantation, 41, 771-778.
34. Hofmeister, C. C., Zhang, J., Knight, K. L., et al. (2007). Ex vivo expansion of umbilical cord blood stem cells for transplantation; growing knowledge from the hematopoietic niche. Bone Marrow Transplantation, 39, 11-23.
35. Delaney, C., Varnum-Finney, B., Aoyama, K., Brashem-Stein, C., & Bernstein, I. D. (2005). Dose-dependent effects of the Notch ligand Delta 1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood, 106, 2693-2699.
36. Bone Marrow Donors Worldwide, Annual Report 2006.
37. Ballen, K. K., Barker, J. N., Stewart, S. K., Greene, M. J., & Lane, T. A. (2008). Collection and preservation of cord blood for personal use. Biology of Blood and Marrow Transplantation, 14, 356-363.
38. Smythe, J., Armitage, S., McDonald, D., Pamphilon, D., Guttridge, M., Brown, J., et al. (2007). Directed sibling cord blood banking for transplantation: the 10-year experience in the National Blood Service in England. Stem Cells, 25, 2087-2093.
39. Rubinstein P. (2009). Cord blood banking. Bone Marrow Transplant (in press).
40. Laskey, L. C., Lane, T. A., Miller, J. R., et al. (2002). In utero or ex utero cord blood collection: which is better? Transfusion, 42, 1261-1267.
41. Chow, R., Nademanee, A., Rosenthal, J., Karanes, C., Jaing, T. H., Graham, M. L., et al. (2007). Biology of Blood and Marrow Transplantation, 13, 1346-1357.
42. Thornley, I., Eapen, M., Sung, L., Lee, S. J., Davies, S. M., & Joffe, S. (2009). Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. Pediatrics, 123, 1011-1017.
43. American Academy of Pediatrics Section on Hematology/Oncology. (2007). Cord blood banking for potential future transplantation. Pediatrics, 119, 165-170.
44. American College of Obstetricians and Gynecologists. (1997). Routine storage of umbilical cord blood for potential future transplantation. ACOG Committee Opinion, 183, 1-3.
45. Ferreria, E., Pasternak, J., Bacal, N., et al. (1999). Autologous cord blood transplantation. Bone Marrow Transplantation, 24, 1041.
46. Fruchtman, S. M., Hurlet, A., Dracker, R., et al. (2004). The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biology of Blood and Marrow Transplantation, 10, 741-742.
47. Rosenthal, J., Bolotin, E., Pawlowska, A., et al. (2007). Hematopoietic stem cell transplantation with autologous cord blood units in two patients with severe aplastic anemia: time for reassessment? Biology of Blood and Marrow Transplantation, 13(suppl 2), 100a.
48. Hayani, A., Lampeter, E., Viswanatha, D., et al. (2007). First report of autologous cord blood transplantation in a child with leukemia. Pediatrics, 119, 296-300.
49. Haller, J. M., Viener, H. L., Wasserfall, C., et al. (2008). Autologous umbilical cord blood infusion for Type I Diabetes. Experimental Hematology, 36, 710-715.
50. Copelan, N., Harris, D., & Gaballa, M. A. (2009). Human umbilical cord blood stem cells, myocardial infarction, and stroke. Clinical Medicine, 9, 342-345.
51. Johnson, F. L. (1997). Placental blood transplantation and autologous banking-caveat emptor. Journal of Pediatric Hematology/Oncology, 19, 183-186.
52. Gratwohl, A., Baldomero, H., Frauendorfer, K., Rocha, V., Apperley, J., & Niederwieser, D. (2008). The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplantation, 41, 687-705.
53. Gale, K. B. (1997). Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proceedings of the National Academy of Sciences of the United States of America, 94, 13950-13954.
54. Koylka, P., Ivanyi, P., & Bruer-Vriesendorp, B. S. (1996). Preservation of immunological and colony-forming capacities of long-term (15 years) cryopreserved cord blood cells. Transplantation, 65, 1275-1278.
55. Broxmeyer, H. E., Srour, E. F., Hangoc, G., Cooper, S., Anderson, S. A., & Bodine, D. M. (2003). High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proceedings of the National Academy of Science, 100, 645-650.
56. Flegel, K. (2009). Ten reasons to make cord blood stem cells a public good. Canadian Medical Association Journal, 180, 1279.
57. Goodwin, H. S., Bicknese, A. R., Chien, S. N., Bogucki, B. D., Quinn, C. O., & Wall, D. A. (2001). Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biology of Blood and Marrow Transplantation, 7, 581-588.
58. Vendrame, M., Cassady, J., Newcomb, J., et al. (2004). Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke, 35, 2390-2395.
59. Ma, N., Stamm, C., Kaminski, A., et al. (2005). Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovascular Research, 66, 45-54.
60. Wu, K. H., Zhou, B., Yu, C. T., Cui, B., Lu, S. H., Han, Z. C., et al. (2007). Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Annals of Thoracic Surgery, 83, 1491-1500.